Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot, Interventional Study of the Specific Anti-HBV Vaccine Response After Vaccination in Patients Requiring Anti-CD20 Monoclonal Antibodies

NCT04519710 is registered in ClinicalTrials.gov with Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida as lead sponsor.

NCT NCT04519710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04519710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot, Interventional Study of the Specific Anti-HBV Vaccine Response After Vaccination in Patients Requiring Anti-CD20 Monoclonal Antibodies
Lead sponsor
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Phase
Not applicable
Overall status
Completed
Start date
September 15, 2020
Completion date
October 15, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hbv